+1 800 987 6007

The era of one-size-fits-all medicine is gradually coming to an end, making way for a more personalized
approach to healthcare. Personalized medicine, also known as precision medicine, tailors medical
treatment to the individual characteristics of each patient. This approach not only considers the patient’s
genetic makeup but also factors in lifestyle and environment, ensuring treatments are as effective and
efficient as possible.

Digital health technologies, particularly Electronic Data Capture (EDC) systems such
as Captivate® are at the forefront of this revolution, providing the tools necessary to make personalized medicine a reality.

Read the full blog below:

Other Guides

  • Captivate™ EDC vs. Paper Data Collection

    Time, Efficiency, and Cost | Is Paper Less Expensive than EDC?
    Historically, a common barrier to entry for implementing Electronic Data Capture (EDC) systems for small studies is the
    upfront costs, a large part of which, comes from professional services fees. Luckily, as technology has evolved, there has
    been an industry-wide shift away from legacy EDC systems, which require p...

    Read more +
  • Crossing the Final Frontier: Space Medicine and Digital Health

    Space exploration has always pushed the boundaries of human knowledge and technology, and as we venture further into the cosmos, the health and well-being of astronauts remain paramount. The unique challenges of the space environment—microgravity, radiation, isolation—demand innovative solutions for medical monitoring and care. Enter the realm of digital health technologies, which have beco...

    Read more +
  • Liquid Biopsy: The Future of Non-Invasive Cancer Diagnostics

    Liquid biopsy is an innovative and increasingly influential method in cancer diagnostics, offering significant advantages over traditional tissue biopsy by detecting cancer information through a simple blood sample. This non-invasive technique allows for the detection of circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), and other cancer-related biomarkers in the bloodstream. In thi...

    Read more +